Related references
Note: Only part of the references are listed.Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome
Anurag Singh et al.
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia
Arnon Nagler et al.
HAEMATOLOGICA (2021)
Engineered off-the-shelf therapeutic T cells resist host immune rejection
Feiyan Mo et al.
NATURE BIOTECHNOLOGY (2021)
Current Concepts and Advances in Graft-Versus-Host Disease Immunology
Geoffrey R. Hill et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions
Nuria Martinez-Cibrian et al.
BLOOD REVIEWS (2021)
Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications
Claudio Annaloro et al.
FRONTIERS IN IMMUNOLOGY (2021)
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
Scott R. Goldsmith et al.
BLOOD (2021)
GVHD Prophylaxis 2020
Mahasweta Gooptu et al.
FRONTIERS IN IMMUNOLOGY (2021)
60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer Immunotherapy
Nicoletta Cieri et al.
CANCER RESEARCH (2021)
A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key
Asmaa Ferdjallah et al.
FRONTIERS IN PEDIATRICS (2021)
Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching
Garcia-Cadenas Irene et al.
BONE MARROW TRANSPLANTATION (2021)
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia
Denis Claude Roy et al.
LEUKEMIA (2020)
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
Florent Malard et al.
LEUKEMIA (2020)
Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
Louis Williams et al.
FRONTIERS IN IMMUNOLOGY (2020)
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease
Bishwas Shrestha et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
History of hematopoietic cell transplantation: challenges and progress
Noa Granot et al.
HAEMATOLOGICA (2020)
Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study
Marco Zecca et al.
BONE MARROW TRANSPLANTATION (2019)
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
Javier Bolanos-Meade et al.
LANCET HAEMATOLOGY (2019)
Donor-derived CD4+/CCR7+ T-cell impact on acute GVHD incidence following haplo-HCT after reduced intensity conditioning and posttransplant cyclophosphamide
Pauline Varlet et al.
BONE MARROW TRANSPLANTATION (2019)
Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation
L. Axt et al.
BONE MARROW TRANSPLANTATION (2019)
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
Lucas P. Wachsmuth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study
Seema Naik et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
The Evolution of T Cell Depleted Haploidentical Transplantation
Franco Aversa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
Natalia S. Nunes et al.
FRONTIERS IN IMMUNOLOGY (2019)
Incidence of Adenovirus Infection in Hematopoietic Stem Cell Transplantation Recipients: Findings from the AdVance Study
Petr Sedlacek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Allogeneic hematopoietic cell transplantation; the current renaissance
Edward A. Copelan et al.
BLOOD REVIEWS (2019)
Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations
Robert Weinkove et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice
Gregory Ehx et al.
FRONTIERS IN IMMUNOLOGY (2018)
Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
Qunfang Zhang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation
Betty Ky Hamilton
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease
I. Garcia-Cadenas et al.
BONE MARROW TRANSPLANTATION (2017)
PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells
Xiong Ni et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Donor CD19 CART cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity
Arnab Ghosh et al.
NATURE MEDICINE (2017)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant
Victor Tkachev et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent
Diogo Gomes-Silva et al.
CELL REPORTS (2017)
Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future
A. Saad et al.
BONE MARROW TRANSPLANTATION (2017)
Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options
Shigeo Fuji et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2017)
Acute Graft Versus Host Disease: A Comprehensive Review
Samah Nassereddine et al.
ANTICANCER RESEARCH (2017)
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Pierre Teira et al.
BLOOD (2016)
Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells
Scott N. Furlan et al.
BLOOD (2016)
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U. Kawalekar et al.
IMMUNITY (2016)
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Partow Kebriaei et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
Katherine G. MacDonald et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease
Jennifer N. Brudno et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality
Margaret L. MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
Zeguo Zhao et al.
CANCER CELL (2015)
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Marie Therese Rubio et al.
HAEMATOLOGICA (2015)
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Marie Therese Rubio et al.
HAEMATOLOGICA (2015)
EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT
L. Rasche et al.
BONE MARROW TRANSPLANTATION (2014)
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
James N. Kochenderfer et al.
BLOOD (2013)
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood
Minji Byun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment
Anthony D. Sung et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Moa Fransson et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Selectively T Cell-Depleted Allografts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplantation Immunosuppression to Improve Transplantation Outcome in Patients with Hematologic Malignancies
Stephan Mielke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression
Weston P. Miller et al.
BLOOD (2010)
Allogeneic hematopoietic cell transplantation: the state of the art
Boglarka Gyurkocza et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer
Robert R. Jenq et al.
NATURE REVIEWS CANCER (2010)
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex
M. A. King et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
The significance of OX40 and OX40L to T-cell biology and immune disease
Michael Croft et al.
IMMUNOLOGICAL REVIEWS (2009)
CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors
Xupeng Ge et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Persis J. Amrolia et al.
BLOOD (2006)
A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy
I. Yakoub-Agha et al.
LEUKEMIA (2006)
Activation-associated phenotype of CD3+ T cells in acute graft-versus-host disease
M. Paz Morante et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: Comparison with B7.1 and 4-1BBL
L Serghides et al.
JOURNAL OF IMMUNOLOGY (2005)
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation
SR Solomon et al.
BLOOD (2005)
Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation
J Sanchez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease
VT Ho et al.
BONE MARROW TRANSPLANTATION (2004)
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukernic responses
PJ Amrolia et al.
BLOOD (2003)
Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response
N Ukyo et al.
IMMUNOLOGY (2003)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
APCs in the liver and spleen recruit, activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease
Y Zhang et al.
JOURNAL OF IMMUNOLOGY (2002)
Allogeneic hematopoietic stem cell transplantation - Complications and results
IA Tabbara et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells
M Guimond et al.
BLOOD (2002)
Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation:: a phase 1/2 study
I André-Schmutz et al.
LANCET (2002)
Share Paper
